Prognostic value of ERBB-1, VEGF, cyclin A, FOS, JUN and MYC in patients with squamous cell lung carcinomas.

Por Volm, M., Rittgen, W., Drings, P.
Publicado em 1998

Primary staging and follow-up in melanoma patients – monocenter evaluation of methods, costs and patient survival

Por Hofmann, U, Szedlak, M, Rittgen, W, Jung, E G, Schadendorf, D
Publicado em 2002

Lack of clinical efficacy of imatinib in metastatic melanoma

Por Ugurel, S, Hildenbrand, R, Zimpfer, A, La Rosée, P, Paschka, P, Sucker, A, Keikavoussi, P, Becker, J C, Rittgen, W, Hochhaus, A, Schadendorf, D
Publicado em 2005